Clinical Trial: Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Study Status: Completed
Recruit Status: RECRUITING
Condition: IC-MPGN
Study Type: INTERVENTIONAL
Official Title: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune Complex Mediated Membranoproliferative
Brief Summary:
This study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in idiopathic immune complex mediated membranoproliferative glomerulonephritis.
Read more